Video: Panel: Avandia to Remain on Market
Thursday, July 15, 2010 - 05:21
in Health & Medicine
After years of debate over Avandia's safety, an advisory panel voted that the drug should remain an option for diabetes patients. As Jon LaPook reports, its fate now lies with the FDA.